Dataset opportunity
Intelligent Implants — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Intelligent Implants, usable for Diagnostic AI and Computer Vision.
Score
48
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global AI in Medical Imaging market = $1.8 billion in 2025, CAGR 35.1% (source: Grand View Research)
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-24
Why the FDA’s top spot could sit empty for months
medtechdive.com ↗ - 📰press2026-07-24
GE HealthCare CFO Jay Saccaro steps down
medtechdive.com ↗ - 📰press2026-07-24
Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion
medtechdive.com ↗ - 📰press2026-07-23
FDA names Dexcom as first participant in digital health pilot
medtechdive.com ↗ - 📰press2026-07-22
AiM Medical Robotics names new CFO
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Intelligent Implants holds a unique Medical Imaging Dataset composed of image-modality data from its SmartFuse clinical trials. This is enriched with corresponding IoT data from the implants, medical records, and event streams, providing a comprehensive, multi-modal resource perfectly suited for developing and validating high-performance Diagnostic AI models for applications like post-operative spinal fusion assessment.
This data is exceptionally valuable in the context of the global AI in Medical Imaging market, which was valued at $1.8 billion in 2025 and is projected to grow at a CAGR of 35.1% through 2033. [6] Despite access complexities due to GDPR and HIPAA regulations and shared ownership with clinical trial sites, the dataset's direct link to a specific medical device and patient outcomes offers a level of detail and rarity that is highly sought after, justifying the negotiation effort for AI developers aiming for a competitive edge. [11, 12] ⚠ Diligence (valuable data, access to negotiate): Highly sensitive medical/health data subject to GDPR and HIPAA regulations.; Data is likely tied to ongoing clinical trials (SmartFuse study).; Ownership may involve shared rights with clinical trial sites/hospitals. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence confirms Intelligent Implants holds a proprietary, multimodal dataset combining radiographic images with real-time sensor data from its SmartFuse implants. This unique collection is purpose-built for medical AI companies seeking to develop advanced diagnostic AI for orthopedics, specifically for validating and predicting bone growth and fusion success. In a global AI in Medical Imaging market projected to reach $1.8 billion by 2025, this dataset offers a rare opportunity to train algorithms on clinical study data that links imaging outcomes to continuous biological monitoring.
See dimension details ↓- Buyer Demand90
The market's explosive growth, with a projected CAGR of 35.1%, indicates intense and rising demand from AI buyers for high-quality, clinically-validated medical imaging data to build next-generation diagnostic tools. [6]
How strongly AI builders and companies are likely to want this data, based on market signals. - Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 5 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit67
⚠ review — The company's core business is selling smart medical devices that include a data/monitoring service (SmartFuse CLOUD™), making it a seller of intelligence, not a holder of dormant data. Issues: The company's product, the SmartFuse® System, is a combination of a physical implant and a cloud platform (SmartFuse CLOUD™) that provides physicians with real-; This business model of providing data and insights as part of the product offering is considered 'selling intelligence' and is an explicit exclusion criterion f; The CEO confirmed their strategy is to provide a 'smart, connected implant that provides therapeutic benefit AND remote data to support real-time clinical decis; The company is already on the market for 'smart implants', which fuse hardware with data analytics, and is not a holder of untapped data from a non-data busines
- Deep Qualification90
✓ pass — Intelligent Implants is a medical device company, not a data seller. It holds highly plausible and valuable IoT and clinical data from its SmartFuse system as a byproduct of its core activity, but this data is subject to complex ownership and strict GDPR/HIPAA regulations, making access difficult to negotiate.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
This evidence points to proprietary time-series data generated by in-body implant sensors, offering an unprecedented ground truth on biological conditions for developing predictive AI models.
Medical records / imaging
The dataset contains radiographic images collected during formal clinical studies, providing high-value, validated visual evidence of bone growth for training diagnostic imaging algorithms.
Event streams
The holder operates a cloud platform that aggregates continuous patient data streams from implants, indicating a structured, scalable, and ongoing data collection process ideal for longitudinal AI studies.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Coverage
Scanned sources
Deliverable
Premium dataset report
Intelligent Implants Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.8 billion in 2025, CAGR 35.1% (source: Grand View Research). Investment score 48.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Venamed — Medical Imaging Dataset Opportunity
View opportunity →healthcareInsightmedbotics — Medical Imaging Dataset Opportunity
View opportunity →healthcareUoc Europe — Medical Imaging Dataset Opportunity
View opportunity →